HCPLive
American Heart Association 2012

American Heart Association 2012 | AHA 2012

According to the AHA, “Scientific Sessions is the leading cardiovascular meeting in the country with over 17,000 professionals attending annually, and over 22,000 total attendees, as reported by the Healthcare Convention and Exhibitor’s Association. Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives.

Conference Coverages

Reducing Cardiovascular Events in Patients with Acute Coronary Syndrome
Reducing Cardiovascular Events in Patients with Acute Coronary Syndrome
A substudy of the PLATO trial reveals that treatment with ticagrelor reduces cardiovascular death, myocardial infarction, and stroke in some patients with non-ST-elevation acute coronary syndrome.
Serelaxin Shows Promise in Treating Acute Heart Failure
Results from the RELAX-AHF show serelaxin reduces cardiovascular deaths and improves symptoms in patients with heart failure.
Ticagrelor May Reduce Cardiovascular Events in Patients with Extensive Coronary Artery Disease
Results from a substudy of the PLATO trial show that patients with extensive CAD and high rates of recurrent cardiovascular events, death, and bleeding may benefit from treatment with ticagrelor.
Visible Signs of Aging Can Predict Increased Risk of Heart Disease
Study results presented at the American Heart Association 2012 Scientific Sessions show that visible signs of aging such as baldness and yellow fatty deposits around the eye are predictors for heart attack and heart disease risk.
Undetected Hypertension Common among Young Adults
Many young adults age 18-24 with high blood pressure remain undiagnosed with hypertension, even after long-term physician care.
Heart-related Deaths More Likely to Occur in Winter, but Cold Weather Not a Major Factor
New research presented at the American Heart Association 2012 Scientific Sessions reveals that although the number of cardiovascular-related deaths increases during the winter months in the US, the rate increase is consistent across climates.
VIDEO: M. Amin Karami, PhD, discusses piezoelectric pacemakers at the AHA 2012 Scientific Sessions
M. Amin Karami, PhD, discusses study results presented at AHA 2012 that demonstrated the technical feasibility of using a piezoelectric energy-harvesting device to power a pacemaker.
Use of ‘Polypill' Combination Drugs Improves Medication Adherence in Patients with Heart Disease
Results from the UMPIRE study show that use of fixed-dose combination cardiovascular drugs improve medication adherence and improve blood pressure and cholesterol levels in patients.
Fish Oil Supplementation Does Not Prevent Irregular Heart Rhythm after Surgery
Results from the OPERA trial presented at AHA 2012 show that short-term use of fish oil supplements does not decrease post-operative atrial fibrillation.

Most Popular

@MDMagazine

$vacMongoViewPlus$ $vAR$